| Primary |
| Rheumatoid Arthritis |
32.4% |
| Product Used For Unknown Indication |
19.6% |
| Crohn's Disease |
14.8% |
| Drug Use For Unknown Indication |
6.8% |
| Juvenile Arthritis |
4.1% |
| Psoriatic Arthropathy |
3.4% |
| Psoriasis |
2.9% |
| Hypertension |
2.2% |
| Ankylosing Spondylitis |
2.0% |
| Colitis Ulcerative |
1.8% |
| Prophylaxis |
1.7% |
| Drug Exposure During Pregnancy |
1.6% |
| Maternal Exposure Timing Unspecified |
1.2% |
| Pain |
0.9% |
| Pustular Psoriasis |
0.9% |
| Diabetes Mellitus |
0.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.8% |
| Gastric Disorder |
0.7% |
| Seronegative Arthritis |
0.7% |
| Inflammatory Bowel Disease |
0.6% |
|
| Drug Exposure During Pregnancy |
15.6% |
| Abortion Spontaneous |
12.6% |
| Foetal Exposure During Pregnancy |
6.7% |
| Lung Infection |
5.2% |
| No Therapeutic Response |
5.2% |
| Pneumonia |
5.2% |
| Sarcoidosis |
5.2% |
| Tuberculosis |
5.2% |
| Multi-organ Failure |
4.4% |
| Liver Injury |
3.7% |
| Renal Failure |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Abortion Induced |
3.0% |
| Colectomy |
3.0% |
| Cough |
3.0% |
| Drug Ineffective |
3.0% |
| Fistula |
3.0% |
| Granuloma |
3.0% |
| Hepatosplenic T-cell Lymphoma |
3.0% |
| Loss Of Consciousness |
3.0% |
|
| Secondary |
| Rheumatoid Arthritis |
27.9% |
| Crohn's Disease |
17.0% |
| Product Used For Unknown Indication |
11.0% |
| Psoriatic Arthropathy |
9.2% |
| Psoriasis |
7.5% |
| Colitis Ulcerative |
7.1% |
| Drug Use For Unknown Indication |
4.4% |
| Juvenile Arthritis |
3.7% |
| Ankylosing Spondylitis |
1.7% |
| Inflammatory Bowel Disease |
1.7% |
| Hypertension |
1.3% |
| Pustular Psoriasis |
1.2% |
| Gastritis |
1.2% |
| Polyarthritis |
1.0% |
| Arthritis |
1.0% |
| Scleritis |
0.9% |
| Prophylaxis |
0.8% |
| Sjogren's Syndrome |
0.7% |
| Gastric Disorder |
0.5% |
| Behcet's Syndrome |
0.5% |
|
| Dermatitis Bullous |
10.3% |
| Psoriasis |
10.3% |
| Pyrexia |
6.9% |
| Thrombocytopenia |
6.9% |
| Drug Ineffective |
6.6% |
| Splenectomy |
6.2% |
| Tuberculosis |
6.2% |
| Psoriatic Arthropathy |
5.2% |
| Sepsis |
4.5% |
| Breast Cancer |
4.1% |
| Pneumonia |
4.1% |
| Lupus-like Syndrome |
3.8% |
| Sarcoidosis |
3.8% |
| Weight Decreased |
3.4% |
| Hodgkin's Disease |
3.1% |
| Lung Neoplasm Malignant |
3.1% |
| Pustular Psoriasis |
3.1% |
| Hepatosplenic T-cell Lymphoma |
2.8% |
| Herpes Zoster |
2.8% |
| Non-hodgkin's Lymphoma |
2.8% |
|
| Concomitant |
| Rheumatoid Arthritis |
27.0% |
| Crohn's Disease |
19.6% |
| Drug Use For Unknown Indication |
14.3% |
| Product Used For Unknown Indication |
10.3% |
| Psoriasis |
6.0% |
| Inflammatory Bowel Disease |
3.2% |
| Hypertension |
3.0% |
| Psoriatic Arthropathy |
3.0% |
| Pain |
2.3% |
| Colitis Ulcerative |
2.2% |
| Ankylosing Spondylitis |
1.2% |
| Arthritis |
1.2% |
| Osteoporosis |
1.1% |
| Premedication |
1.1% |
| Wegener's Granulomatosis |
1.1% |
| Prophylaxis |
0.9% |
| Blood Cholesterol Increased |
0.7% |
| Routine Health Maintenance |
0.7% |
| Anxiety |
0.6% |
| Arthralgia |
0.6% |
|
| Crohn's Disease |
23.1% |
| Drug Ineffective |
7.5% |
| Psoriasis |
7.5% |
| Pyrexia |
6.0% |
| Rheumatoid Arthritis |
5.5% |
| Vomiting |
5.0% |
| Prostate Cancer |
4.5% |
| Therapeutic Response Decreased |
4.5% |
| Pneumonia |
4.0% |
| Weight Decreased |
4.0% |
| Constipation |
3.5% |
| Pancreatic Carcinoma |
3.5% |
| Septic Shock |
3.5% |
| Diverticulitis |
3.0% |
| Flushing |
2.5% |
| Psoriatic Arthropathy |
2.5% |
| Rash |
2.5% |
| Renal Failure |
2.5% |
| Respiratory Failure |
2.5% |
| Anal Fistula |
2.0% |
|
| Interacting |
| Ankylosing Spondylitis |
40.0% |
| Menorrhagia |
20.0% |
| Neuralgia |
20.0% |
| Psoriatic Arthropathy |
20.0% |
|
| Liver Function Test Abnormal |
50.0% |
| Psoriasis |
50.0% |
|
